FDA Adverse Event Injury Summary report: N

ACCESS 2 IMMUNOASSAY SYSTEM

MDR report key: 2161806 · Received July 8, 2011

Report

Report Number
2122870-2011-02132
Event Type
Injury
Date Received
July 8, 2011
Date of Event
December 13, 2008
Report Date
December 14, 2008
Manufacturer
BECKMAN COULTER, INC.
Product Code
MMI
PMA / PMN Number
K922823/A007
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

SERVICE WAS DISPATCHED TO THE SITE BUT WAS CANCELLED ON (B)(4) 2008 BECAUSE THE CUSTOMER HAS A BCI TRAINED BIO MED ONSITE. THE BIO MED TECHNICIAN PERFORMED HIGH SENSITIVITY SYSTEM CHECK WHICH PASSED WITHIN PUBLISHED SPECIFICATIONS. A DEFINITIVE ROOT CAUSE COULD NOT BE DETERMINED FOR THIS EVENT. THIS IS FOUR OF FIVE SEPARATE MDR REPORTS RELATED TO FIVE PATIENT EVENTS ASSOCIATED WITH A SINGLE MALFUNCTION REPORT. REFERENCE MDR NUMBERS: MDR 2122870-2011-02129, MDR 2122870-2011-02130, MDR 2122870-2011-02131, MDR 2122870-2011-02133 FOR ALL RELATED EVENTS. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A RETROSPECTIVE REVIEW OF COMPLAINTS CONDUCTED BETWEEN (B)(6), 2008 THROUGH (B)(6), 2010 FOR ADDITIONAL REPORTABLE EVENTS.

Description of Event or Problem · 1

THE CUSTOMER CONTACTED BECKMAN COULTER, INC. (BCI) IN REGARDS TO ERRONEOUSLY ELEVATED ACCUTNI (TROPONIN I) RESULTS GENERATED ON THE ACCESS 2 IMMUNOASSAY SYSTEM FOR FIVE PATIENTS. THE PATIENT SAMPLES WERE RETESTED AND THE RESULTS WERE WITHIN THE NORMAL REFERENCE RANGE. THE INITIAL ERRONEOUSLY ELEVATED RESULTS WERE REPORTED OUTSIDE THE LABORATORY. THE PATIENT WAS ADMITTED TO THE HOSPITAL DUE TO THE ELEVATED ACCUTNI RESULTS. NO FURTHER INFORMATION IS AVAILABLE RELATING TO ANY FURTHER TREATMENT OR CARE. IT IS; THEREFORE, UNKNOWN IF ANY FURTHER TREATMENT OR CARE WAS PROVIDED AS A RESULT OF THE HOSPITALIZATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACCESS 2 IMMUNOASSAY SYSTEM MMI BECKMAN COULTER, INC. NA NA

Patients

Seq Age Sex Outcome Treatment
1 UNK Hospitalization ACCESS ACCUTNI